Clinical Trials Directory

Trials / Completed

CompletedNCT03507400

Introvision for Migraine and Headaches

Treatment of Migraine With Introvision, a Method of Mental Self-regulation - IntroMig: Randomised Waiting-list Control Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effect of Introvision, a mental and emotional self-regulation-technique developed by Angelika C. Wager, as migraine preventative compared to a waiting list group.

Detailed description

Randomized, single-center, waiting-list control group study: Introvision as preventative in Migraine Randomized, single center, waiting-list group control study to evaluate the effect of Introvison, a mental and emotional self regulation method to reduce headache days in patients with migraine, migraine and tension type headache and chronic migraine. The number of headache days 3 months after completion of the last session of Introvision will be compared with the number of headache days of the waiting list group in the month before the course to learn Introvision.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntrovision: mental and emotional self-regulationParticipants learn Introvision

Timeline

Start date
2017-09-20
Primary completion
2019-09-11
Completion
2020-07-19
First posted
2018-04-25
Last updated
2025-04-18
Results posted
2025-04-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03507400. Inclusion in this directory is not an endorsement.

Introvision for Migraine and Headaches (NCT03507400) · Clinical Trials Directory